Utility of behavioral science techniques in assessing adverse effects of antihypertensive agents.
Noncompliance of hypertensive patients to their treatment program is a common problem. The basis of this noncompliance is multifactorial, but a large component is related to the adverse symptoms produced by the commonly prescribed antihypertensive agents. There is increasing evidence that one can use social and behavioral science techniques to quantitate the effect of antihypertensive agents on a patient's quality of life. Thus, in addition to efficacy, serious side effects, and cost, the physician also now will be able to add impact on quality of life as a fourth dimension in determining which antihypertensive program is the most appropriate.
Williams
G H
GH
D000328:Adult; D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002216:Captopril / Q000009:adverse effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008750:Methyldopa / Q000009:adverse effects; D008875:Middle Aged; D010349:Patient Compliance; D011433:Propranolol / Q000009:adverse effects; D011788:Quality of Life; D012107:Research Design
D000959:Antihypertensive Agents; D008750:Methyldopa; D002216:Captopril; D011433:Propranolol